Lysosomes in glioblastoma: pump up the volume

References

• Lathia JD, Mack SC, Mulkearns-Hubert EE, et al. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203–1217.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996.
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–466.
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–760.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Yu T-S, et al. a restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488:522–526.
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401.
   PubMed Web of Science ®Google Scholar
• Jacobs KA, André‐Grégoire G, Maghe C, et al. Paracaspase MALT1 regulates glioma cell survival by controlling endo‐lysosome homeostasis. Embo J. 2020;39:e102030.
   Web of Science ®Google Scholar
• Le Joncour V, Filppu P, Hyvönen M, et al. Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization. EMBO Mol Med. 2019;11:e9034.
   PubMed Web of Science ®Google Scholar
• Shingu T, Ho AL, Yuan L, et al. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation. Nat Genet. 2017;49:75–86.
   PubMed Web of Science ®Google Scholar
• de Duve C, Pressman BC, Gianetto R, et al. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J. 1955;60:604–617.
   PubMed Web of Science ®Google Scholar
• Conus S, Simon H-U. Cathepsins: key modulators of cell death and inflammatory responses. Biochem Pharmacol. 2008;76:1374–1382.
   PubMed Web of Science ®Google Scholar
• Eskelinen E-L, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13:137–145.
   PubMed Web of Science ®Google Scholar
• Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol. 1989;5:483–525.
   PubMedGoogle Scholar
• Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol. 2009;10:623–635.
   PubMed Web of Science ®Google Scholar
• Sardiello M, Palmieri M, Di Ronza a, et al. a gene network regulating lysosomal biogenesis and function. Science. 2009;325:473–477.
   PubMed Web of Science ®Google Scholar
• Settembre C, Ballabio a. TFEB regulates autophagy: an integrated coordination of cellular degradation and recycling processes. Autophagy. 2011;7:1379–1381.
   PubMed Web of Science ®Google Scholar
• Napolitano G, Ballabio a. TFEB at a glance. J Cell Sci. 2016;129:2475–2481.
   PubMed Web of Science ®Google Scholar
• Martina JA, Chen Y, Gucek M, et al. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 2012;8:903–914.
   PubMed Web of Science ®Google Scholar
• Roczniak-Ferguson a, Petit CS, Froehlich F, et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal. 2012;5:ra42–ra42.
   PubMed Web of Science ®Google Scholar
• Sakamaki J, Wilkinson S, Hahn M, et al. Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function. Mol Cell. 2017;66:517–532.e9.
   PubMed Web of Science ®Google Scholar
• Dahms NM. Insulin-like growth factor II/cation-independent mannose 6-phosphate receptor and lysosomal enzyme recognition. Biochem Soc Trans. 1996;24:136–141.
   PubMed Web of Science ®Google Scholar
• Gary-Bobo M, Nirdé P, Jeanjean a, et al. Mannose 6-phosphate receptor targeting and its applications in human diseases. Curr Med Chem. 2007;14:2945–2953.
   PubMed Web of Science ®Google Scholar
• Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem. 1992;61:307–330.
   PubMed Web of Science ®Google Scholar
• Munier-Lehmann H, Mauxion F, Hoflack B. Function of the two mannose 6-phosphate receptors in lysosomal enzyme transport. Biochem Soc Trans. 1996;24:133–136.
   PubMed Web of Science ®Google Scholar
• Kirchhausen T, Owen D, Harrison SC. Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. Cold Spring Harb Perspect Biol. 2014;6:a016725.
   PubMed Web of Science ®Google Scholar
• Ross E, Ata R, Thavarajah T, et al. AMP-activated protein kinase regulates the cell surface proteome and integrin membrane traffic. Plos One. 2015;10:e0128013.
   PubMed Web of Science ®Google Scholar
• Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19:349–364.
   PubMed Web of Science ®Google Scholar
• Settembre C, Fraldi a, Medina DL, et al. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 2013;14:283–296.
   PubMed Web of Science ®Google Scholar
• Ganley IG, Lam DH, Wang J, et al. ULK1·ATG13·FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem. 2009;284:12297–12305.
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, et al. Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol Biol Cell. 2009;20:1981–1991.
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro S-H, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009;20:1992–2003.
   PubMed Web of Science ®Google Scholar
• Puente C, Hendrickson RC, Jiang X. Nutrient-regulated phosphorylation of ATG13 inhibits starvation-induced autophagy. J Biol Chem. 2016;291:6026–6035.
   PubMed Web of Science ®Google Scholar
• Huynh C, Roth D, Ward DM, et al. Defective lysosomal exocytosis and plasma membrane repair in Chediak-Higashi/beige cells. Proc Natl Acad Sci U S A. 2004;101:16795–16800.
   PubMed Web of Science ®Google Scholar
• Jaiswal JK, Andrews NW, Simon SM. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol. 2002;159:625–635.
   PubMed Web of Science ®Google Scholar
• Reddy a, Caler EV, Andrews NW. Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell. 2001;106:157–169.
   PubMed Web of Science ®Google Scholar
• Machado E, White-Gilbertson S, Vlekkert D, et al. Regulated lysosomal exocytosis mediates cancer progression. Sci Adv. 2015;1:e1500603.
   PubMed Web of Science ®Google Scholar
• Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960–976.
   PubMed Web of Science ®Google Scholar
• Brunk UT, Ericsson JL. Cytochemical evidence for the leakage of acid phosphatase through ultrastructurally intact lysosomal membranes. Histochem J. 1972;4:479–491.
   PubMedGoogle Scholar
• Firestone RA, Pisano JM, Bonney RJ. Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents. J Med Chem. 1979;22:1130–1133.
   PubMed Web of Science ®Google Scholar
• Aits S, Jäättelä M. Lysosomal cell death at a glance. J Cell Sci. 2013;126:1905–1912.
   PubMed Web of Science ®Google Scholar
• Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11:1437–1438.
   PubMed Web of Science ®Google Scholar
• Nakashima S, Hiraku Y, Tada-Oikawa S, et al. Vacuolar H+-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem (Tokyo). 2003;134:359–364.
   PubMed Web of Science ®Google Scholar
• Mauthe M, Orhon I, Rocchi C, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14:1435–1455.
   PubMed Web of Science ®Google Scholar
• Zhou J, Tan S-H, Nicolas V, et al. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion. Cell Res. 2013;23:508–523.
   PubMed Web of Science ®Google Scholar
• Loison F, Zhu H, Karatepe K, et al. Proteinase 3–dependent caspase-3 cleavage modulates neutrophil death and inflammation. J Clin Invest. 2014;124:4445–4458.
   PubMed Web of Science ®Google Scholar
• Zhao K, Zhao X, Tu Y, et al. Lysosomal chymotrypsin B potentiates apoptosis via cleavage of Bid. Cell Mol Life Sci. 2010;67:2665–2678.
   PubMed Web of Science ®Google Scholar
• Boya P, Andreau K, Poncet D, et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med. 2003;197:1323–1334.
   PubMed Web of Science ®Google Scholar
• Kågedal K, Zhao M, Svensson I, et al. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J. 2001;359:335–343.
   PubMed Web of Science ®Google Scholar
• Ostenfeld MS, Høyer-Hansen M, Bastholm L, et al. Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation. Autophagy. 2008;4:487–499.
   PubMed Web of Science ®Google Scholar
• Castino R, Peracchio C, Salini a, et al. Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop. J Cell Mol Med. 2009;13:1096–1109.
   PubMed Web of Science ®Google Scholar
• Groth-Pedersen L, Ostenfeld MS, Høyer-Hansen M, et al. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res. 2007;67:2217–2225.
   PubMed Web of Science ®Google Scholar
• Gabandé-Rodríguez E, Boya P, Labrador V, et al. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type a. Cell Death Differ. 2014;21:864–875.
   PubMed Web of Science ®Google Scholar
• Kirkegaard T, Roth AG, Petersen NHT, et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature. 2010;463:549–553.
   PubMed Web of Science ®Google Scholar
• Gulbins E, Kolesnick RN. It takes a CAD to kill a tumor cell with a LMP. Cancer Cell. 2013;24:279–281.
   PubMed Web of Science ®Google Scholar
• Petersen NHT, Olsen OD, Groth-Pedersen L, et al. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell. 2013;24:379–393.
   PubMed Web of Science ®Google Scholar
• Granato M, Lacconi V, Peddis M, et al. HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma. Cell Death Dis. 2013;4:e730.
   PubMed Web of Science ®Google Scholar
• Nylandsted J, Wick W, Hirt UA, et al. Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res. 2002;62:7139–7142.
   PubMed Web of Science ®Google Scholar
• Papadopoulos C, Meyer H. Detection and clearance of damaged lysosomes by the endo-lysosomal damage response and lysophagy. Curr Biol CB. 2017;27:R1330–R1341.
   PubMed Web of Science ®Google Scholar
• Raben N, Puertollano R. TFEB and TFE3: linking lysosomes to cellular adaptation to stress. Annu Rev Cell Dev Biol. 2016;32:255–278.
   PubMed Web of Science ®Google Scholar
• Lu S, Sung T, Lin N, et al. Lysosomal adaptation: how cells respond to lysosomotropic compounds. Plos One. 2017;12:e0173771.
   PubMed Web of Science ®Google Scholar
• Radulovic M, Schink KO, Wenzel EM, et al. ESCRT-mediated lysosome repair precedes lysophagy and promotes cell survival. Embo J. 2018;37:e99753.
   PubMed Web of Science ®Google Scholar
• Skowyra ML, Schlesinger PH, Naismith TV, et al. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science. 2018;360:eaar5078.
   PubMed Web of Science ®Google Scholar
• Chauhan S, Kumar S, Jain a, et al. TRIMs and galectins globally cooperate and TRIM16 and Galectin-3 Co-direct autophagy in endomembrane damage homeostasis. Dev Cell. 2016;39:13–27.
   PubMed Web of Science ®Google Scholar
• Jia J, Abudu YP, Claude-Taupin a, et al. Galectins control MTOR and AMPK in response to lysosomal damage to induce autophagy. Autophagy. 2019;15:169–171.
   PubMed Web of Science ®Google Scholar
• Jia J, Bissa B, Brecht L, et al. AMPK, a regulator of metabolism and autophagy, is activated by lysosomal damage via a novel galectin-directed ubiquitin signal transduction system. Mol Cell. 2020a;77:951–969.e9.
   PubMed Web of Science ®Google Scholar
• Jia J, Claude-Taupin a, Gu Y, et al. Galectin-3 coordinates a cellular system for lysosomal repair and removal. Dev Cell. 2020b;52:69–87.e8.
   PubMed Web of Science ®Google Scholar
• Thurston TLM, Wandel MP, von Muhlinen N, et al. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature. 2012;482:414–418.
   PubMed Web of Science ®Google Scholar
• Zhitomirsky B, Assaraf YG. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis. Oncotarget. 2017;8:45117–45132.
   PubMedGoogle Scholar
• Ferranti CS, Cheng J, Thompson C, et al. Fusion of lysosomes to plasma membrane initiates radiation-induced apoptosis. J Cell Biol. 2020;219:e201903176.
   PubMed Web of Science ®Google Scholar
• Villegas F, Lehalle D, Mayer D, et al. Lysosomal signaling licenses embryonic stem cell differentiation via inactivation of Tfe3. Cell Stem Cell. 2019;24:257–270.e8.
   PubMed Web of Science ®Google Scholar
• Leeman DS, Hebestreit K, Ruetz T, et al. Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging. Science. 2018;359:1277–1283.
   PubMed Web of Science ®Google Scholar
• Young JS, Chmura SJ, Wainwright DA, et al. Management of glioblastoma in elderly patients. J Neurol Sci. 2017;380:250–255.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee JE, Kahng JY, et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature. 2018;560:243–247.
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821–5828.
   PubMed Web of Science ®Google Scholar
• Kaufmann AM, Krise JP. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J Pharm Sci. 2007;96:729–746.
   PubMed Web of Science ®Google Scholar
• Enzenmüller S, Gonzalez P, Karpel-Massler G, et al. GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death. Cancer Lett. 2013;329:27–36.
   PubMed Web of Science ®Google Scholar
• Zhou W, Guo Y, Zhang X, et al. Lys05 induces lysosomal membrane permeabilization and increases radiosensitivity in glioblastoma. J Cell Biochem. 2020;121:2027–2037.
   PubMed Web of Science ®Google Scholar
• Jensen SS, Petterson SA, Halle B, et al. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo. BMC Cancer. 2017;17:178.
   PubMed Web of Science ®Google Scholar
• Jaishy B, Abel ED. Lipids, lysosomes, and autophagy. J Lipid Res. 2016;57:1619–1635.
   PubMed Web of Science ®Google Scholar
• Lawrence RE, Zoncu R. The lysosome as a cellular centre for signalling, metabolism and quality control. Nat Cell Biol. 2019;21:133–142.
   PubMed Web of Science ®Google Scholar
• Wojton J, Meisen WH, Jacob NK, et al. SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma. Oncotarget. 2014;5:9703–9709.
   Google Scholar
• Mora R, Dokic I, Kees T, et al. Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma: sphingosine kinase and lysosomal cell death. Glia. 2010;58:1364–1383.
   PubMed Web of Science ®Google Scholar
• Hailfinger S, Lenz G, Ngo V, et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci. 2009;106:19946–19951.
   PubMed Web of Science ®Google Scholar
• Jaworski M, Thome M. The paracaspase MALT1: biological function and potential for therapeutic inhibition. Cell Mol Life Sci. 2016;73:459–473.
   PubMed Web of Science ®Google Scholar
• Nagel D, Spranger S, Vincendeau M, et al. Pharmacologic Inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell. 2012;22:825–837.
   PubMed Web of Science ®Google Scholar
• Thys a, Douanne T, Bidère N. Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma. Front Oncol. 2018;8:498.
   PubMed Web of Science ®Google Scholar
• Weil R, Israel a. Deciphering the pathway from the TCR to NF-kB. Cell Death Differ. 2006;13:826–833.
   Web of Science ®Google Scholar
• Schlauderer F, Lammens K, Nagel D, et al. Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase. Angew Chem Int Ed. 2013;52:10384–10387.
   PubMed Web of Science ®Google Scholar
• Galan-Moya EM, Le Guelte a, Lima-Fernandes E, et al. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. EMBO Rep. 2011;12:470–476.
   PubMed Web of Science ®Google Scholar
• Puertollano R. mTOR and lysosome regulation. F1000Prime Rep. 2014;6:52.
   Google Scholar
• Zhitomirsky B, Yunaev a, Kreiserman R, et al. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity. Cell Death Dis. 2018;9:1191.
   PubMed Web of Science ®Google Scholar
• Cuddapah VA, Robel S, Watkins S, et al. a neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014;15:455–465.
   PubMed Web of Science ®Google Scholar
• Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396–1401.
   PubMed Web of Science ®Google Scholar